ACCL2031-A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Kathleen Dorris

Kathleen Dorris

Study ID

Protocol Number: 22-1902

More information available at ClinicalTrials.gov: NCT04939597

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers